Skip to main content

Table 1 Patient characteristics (n = 49)

From: Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer

Age (years)

70 (61–82)

Tumor size (mm)

22 (10–70)

Sex

 Male

27 (55.1)

 Female

22 (44.9)

Primary tumor location

 Head/neck

36 (73.5)

 Body/tail

13 (26.5)

Operation procedure

 Pancreatoduodenectomy

34 (69.4)

 Distal Pancreatectomy

11 (22.4)

 Total Pancreatectomy

4 (8.2)

NCCN resectability (2015)

 Resectable

41 (83.7)

 Borderline resectable

  BR-PVa

7 (14.3)

  BR-Aa

1 (2)

Operation time (min)

477 (231–816)

Intraoperative bleeding (mL)

1360 (231–9268)

Postoperative hospital stays (days)

25 (14–152)

Complication after surgery

12 (24.5)

Uncompleted adjuvant chemotherapy

22 (44.9)

  1. Data are presented as median (range) or n (%). Each value was assessed before neoadjuvant chemoradiotherapy
  2. NCCN, National Comprehensive Cancer Network; BR-PV, borderline resectable with portal vein invasion; BR-A, borderline resectable with arterial invasion
  3. aAccording to NCCN guideline 2018 [1]